Aclaris Therapeutics Inc (ACRS)
Operating Cash Flow Growth
-521.34%
TTM · Period ending:
ACRS Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-521.34%period ending
Latest reported-521.34%period ending
ACRS TTM Cash from Operations YoY % (-166.75% → -521.34%)
Year-over-year change
High-resolution chart · PNG
ACRS operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -521.3356% | |
| -323.8451% | |
| -134.6849% | |
| -139.8033% | |
| 84.5039% | |
| 83.078% | |
| 74.3696% | |
| 80.2622% | |
| 12.8268% | |
| 0.2248% | |
| -15.922% | |
| -38.3842% | |
| -8.2309% | |
| -19.8452% | |
| -29.6026% | |
| -49.2099% | |
| -50.2772% | |
| -38.1548% | |
| -34.9468% | |
| 12.4586% | |
| 25.9308% | |
| 38.7477% | |
| 59.943% | |
| 51.438% | |
| 44.1039% | |
| 34.7597% | |
| 4.3309% | |
| -12.5636% | |
| -45.185% | |
| -72.611% | |
| -84.4227% | |
| -106.1157% | |
| -85.7476% | |
| -58.2342% | |
| -57.9719% | |
| -45.1839% | |
| -29.9544% | |
| -65.03% | |
| -69.8807% | |
| -61.4615% | |
| -212.9345% | |
| -178.1556% | |
| -166.7496% |